# VACCINE AND TREATMENT EVALUATION UNITS: PHASE I TRIAL TO EVALUATE THERAPEUTICS FOR RESISTANT BACTERIAL INFECTIONS

> **NIH NIH N01** · DUKE UNIVERSITY · 2022 · $31,500

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

## Key facts

- **NIH application ID:** 10578643
- **Project number:** 272201300017I-P00006-27200022-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** EMMANUEL B WALTER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $31,500
- **Award type:** —
- **Project period:** 2017-08-28 → 2022-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10578643

## Citation

> US National Institutes of Health, RePORTER application 10578643, VACCINE AND TREATMENT EVALUATION UNITS: PHASE I TRIAL TO EVALUATE THERAPEUTICS FOR RESISTANT BACTERIAL INFECTIONS (272201300017I-P00006-27200022-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10578643. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*